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Abstract
Vitamin A plays an essential role in vertebrate embryogenesis. In the present study, pregnant vitamin A-deficient (VAD) rats were maintained
during early pregnancy on the short half-life vitamin A metabolite, all-trans retinoic acid (atRA), in an amount sufficient to support normal
development to E10.5, with a higher level of atRA (250 μg atRA/g diet) provided from embryonic day (E) 8.5–10.5 to prevent mid-gestational
resorption. When limiting amounts of atRA (1.5 or 12 μg/g diet) were provided after E10.5, a highly reproducible and penetrant state of late fetal
vitamin A deficiency (late VAD) was induced in the organs of developing fetuses. In addition, late VAD fetuses displayed both anteriorization of
cervical regions and novel posteriorization events at the thoracic and sacral levels of the skeleton, and showed sternal and pelvic malformations not
previously observed in early VAD or genetic models. The expression of several Hox genes (Hoxd3 and Hoxb4) was altered in late VAD embryos,
with a reduction in Hoxd3 noted as early as 1 day after instituting deficiency. All late VAD-induced malformations were prevented by the addition
of retinol starting at E10.5, whereas provision of a high level of atRA throughout pregnancy improved but could not completely rescue the
development of all organ systems. This work defines a nutritional model in which vitamin A deficiency can be induced during fetal development,
and reveals new functions for the vitamin in the development of the axial and appendicular skeleton.
© 2007 Elsevier Inc. All rights reserved.Keywords: Anteriorization; Embryonic development; Homeotic transformation; Hox gene; Organogenesis; Posteriorization; Retinoic acid; Rib fusion; Skeletal
development; Sternum; Vitamin A deficiencyIntroduction
Vitamin A (retinol) is essential for vertebrate embryogenesis
(McCaffery and Drager, 2000; Zile, 2001; Clagett-Dame and
DeLuca, 2002; Mark et al., 2006) and severe vitamin A
deficiency leads to complete reproductive failure in the female
(Evans, 1928). Vitamin A is normally obtained in the diet in the
form of retinyl ester or carotenoid and both are metabolized to
retinol. Retinol is stored as an ester in tissues, and is meta-
bolized when needed to retinaldehyde and further oxidized to⁎ Corresponding author. Department of Biochemistry, University of Wisconsin-
Madison, 433 Babcock Drive, Madison, WI 53706-1544, USA. Fax: +1 608 262
7122.
E-mail address: dame@biochem.wisc.edu (M. Clagett-Dame).
0012-1606/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2007.10.018all-trans retinoic acid (atRA). atRA is believed to support all
known functions of vitamin A in mammals with the exception
of vision, although other retinol metabolites have been reported
to have biological activity in vitro (Moise et al., 2007). A large
body of work supports numerous roles for atRA in early deve-
lopmental processes, whereas less is known about the functions
of vitamin A at later times in fetal development.
Studies in the 1940s and 50s provided the first evidence that
vitamin A is needed to support fetal development in the rat
(Warkany and Schraffenberger, 1944, 1946; Wilson and
Warkany, 1948, 1949; Wilson et al., 1953). In these studies, a
large number of female weanling rats were fed a vitamin
A-deficient (VAD) diet and supplemented with small amounts
of β-carotene (and in some cases ground horse muscle) before
mating. Of the pregnant animals, over half either died or re-
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(E14). Fetuses were removed from mothers showing abnormal
bleeding (indicative of the onset of resorption) and upon more
detailed histological examination, a variety of organ defects
were reported and coined the “vitamin A deficiency syndrome”.
However, the penetrance of the defects across the embryos
surveyed was highly variable ranging from 4% to 42% for most
systems (urogenital organs, kidneys, diaphragm and lung;
Wilson et al., 1953). Thus, in these early studies, the severity of
the deficiency varied from animal to animal, in large part
because β-carotene can be converted to retinol and stored. This
nutritional approach to study the effect of VAD on organogen-
esis was therefore limited by its lack of penetrance and the
variable nature of the timing of deficiency.
In 1946, Arens and van Dorp reported the synthesis of atRA,
and subsequent studies showed that it could support the growth
of VAD animals (Arens and van Dorp, 1946a,b). Later studies
revealed that the amount of atRA that would support growth in
the non-pregnant animal (2–12 μg/g diet or ∼40–230 μg/rat/
day) could also support the early but not later stages of
pregnancy. When this amount of atRA was provided to the
pregnant VAD mother, embryos formed, but the conceptus was
always resorbed at midgestation (Thompson et al., 1964; White
et al., 1998). More recently, our group has shown that
supplementation of VAD rats with an even higher level of
atRA (250 μg/g diet or ∼4 mg/rat/day), either from the onset of
pregnancy or after E8.5, can prevent embryonic resorption at
midgestation (White et al., 1998, 2000). The need for higher
amounts of atRA starting at the late gastrula (presomite stage) to
neurula stage coincides with the time when the rodent embryo
begins to synthesize its own atRA (Rossant et al., 1991;
Niederreither et al., 1997; Ulven et al., 2000). White et al.
(2000) showed that if female VAD rats are fed atRA at a level of
12 μg/g diet from E0.5 to 8.5 and 250 μg atRA/g diet from E8.5Fig. 1. Maternal dietary treatment groups and fetal outcome at embryonic day (E) 18.5. V
with 500 IU of retinol (ROL) per day in the form of retinyl palmitate and were sacrifi
[live / (live+dead+resorbed)]×100%}. The mean number of live fetuses/litter in gro
analyzed for each group (I–VIII) was 3, 3, 4, 4, 3, 3, 4, and 4, respectively. atRA, all-tto 10.5 followed by daily oral dosing with retinyl palmitate
(RP), live offspring are produced that give rise to a second
generation. Thus, simply by increasing the maternal intake of
atRA at this critical time, fetal resorption at later times can be
overcome and development can proceed.
In the present study, we describe a nutritional model that
produces late VAD in rat fetuses with defects in organogenesis
that are highly reproducible and fully penetrant. In this model,
pregnant VAD animals are supported during early gestation
(E0.5 to E8.5) on an adequate level of atRA followed by the
feeding of higher atRA through approximately the 12- to 15-
somite stage to prevent mid-gestational death. Placing the
animals on a lower level of dietary atRA after E10.5 produces a
state of late fetal VAD, whereas supplementation with retinol
(RP) after E10.5 yields fetuses that appear histologically normal
at E18.5 and E21.5. The model takes advantage of the short
biological half-life of atRA and the fact that this metabolite is
not stored, thus enabling production of VAD at a precise time in
later development. Using this late VAD rat model, unique
defects in the thoracic, sacral and pelvic regions of the deve-
loping skeleton are also revealed.
Materials and methods
Generation of rat embryos
Female rats (Harlan Sprague-Dawley, Madison, WI) were depleted of
vitamin A as previously described (White et al., 1998). The VAD rats were
placed back on a maintenance level of atRA (12 μg atRA/g diet) for a
minimum of 2 weeks prior to mating; E0.5 was defined as 12 p.m. of the day
that the rat was determined to be sperm-positive. The rats were then assigned to
the dietary treatment groups shown in Fig. 1. Analysis of the atRA content of
the diet was carried out as described previously and was found to be ±10% of
the desired value (White et al., 1998). Food intake was measured daily from
E0.5 to the day of sacrifice. In the high atRA-containing diet group (250 μg/g),
only animals that consumed at least 11 g of food/day from E8.5 to E10.5 wereAD rats were fed diets containing one of two atRA levels and/orwere dosed orally
ced at E18.5. Fetal survival is shown in the right-hand column {% Live fetuses=
ups I–VIII was 11, 0, 10, 1, 8, 9, 9 and 11, respectively. The number of litters
rans retinoic acid; IU, international units. ⁎p value b0.05 compared with group I.
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averaged 16±2 g/day.
Histological analysis of the embryos
At either E18.5 or E21.5, pregnant rats were sacrificed and the anaesthetized
fetuses were fixed in Bouin's solution (VWR Scientific Products, West Chester,
PA) or ethanol at 4 °C. Bouin's-fixed fetuses were washed in phosphate-buffered
saline at 4 °C, dehydrated to 100% ethanol, embedded in paraffin under vacuum
and sectioned transversely at 10 μm. Sections were stained using Groat's
Hematoxylin and Mallory's Trichrome stain (Mark et al., 1993). For skeletal
analysis, E21.5 fetuses were partially skinned, fixed in ethanol and stained for
bone and cartilage using Alcian blue and Alizarin red as described previously
(Lufkin et al., 1992). Five to seven fetuses from three separate litters were
sectioned for each treatment group and time point, and 6 to 12 fetuses from 3 to 6
litters were stained for bone and cartilage in each treatment group. Comparative
images of various skeletal regions were taken at the same magnification.
Measurement of the dentary, nasal and incisor bones was made from digital
images using MetaMorph software (Universal Imaging Corporation, West
Chester, PA). Fetal survival and bone length were analyzed using a one-way
analysis of variance (ANOVA) followed by pairwise comparisons (Tukey's
HSD, Sheffe's Test and Fisher's test; significance set at Pb0.05).
In situ hybridization analysis of embryos
In situ hybridization of whole rat embryos (E11.5–E13.5) and floating
sections (E15.5 and E16.5) was performed as described (Kaiser et al., 2003). The
Hoxd3 and Hoxd4 ribroprobes were generated as described (Kaiser et al., 2003)
and a 337-bp rat Wnt3a probe was prepared using a cDNA generated by PCR
using the primers: 5′-attcccagagcctgctgttca-3′ and 5′-atcacttttgtctaaatccagtg-
3′. The Hoxb4 probe was a kind gift from Dr. R. Krumlauf (Stowers Institute,
Kansas City, MO). For vibratome sections, embryos were embedded in 3%
agarose in PBS at 65 °C and stored overnight at 4 °C prior to sectioning.
Results
The addition of either ROL or a high level of atRA at the late
gastrula/early neural stage supports fetal survival to E18.5
The result of supplementing the diets of VAD rats with
either atRA (12 or 250 μg/g) and/or giving oral retinol (ROL)
at various times during pregnancy on fetal outcome (percent
live fetuses) at E18.5 is shown in the right column in Fig. 1.
The administration of ROL to VAD rats starting at the onset of
pregnancy or E0.5 (group I) yielded live fetuses (94%) when
assessed at E18.5. In contrast, no live fetuses were present in
the group maintained on the low level of atRA (12 μg/g diet;
group II). This level of atRA has been shown previously to be
insufficient to support embryo survival beyond midgestation,
and thus served as a control to verify that the rats were depleted
of vitamin A stores prior to mating (White et al., 1998). When
ROL was added at E9.5 (group III), the majority of fetuses
taken at E18.5 were alive (90%), whereas if the addition of
ROL was delayed by 1 day (E10.5), nearly all fetuses were
resorbed (group IV). In order to determine whether atRA could
substitute for ROL during this critical time, a pharmacological
amount of atRA (250 μg atRA/g diet) was given from E8.5 to
E10.5 and was followed by daily supplementation with ROL
starting at E10.5 (group V). Because the diet served as the
means to deliver atRA, it was made available to the pregnant
animals starting at E8.5 to insure that sufficient retinoid was
available during the critical E9.5–E10.5 window of time. Thisresulted in normal fetal survival (96%) showing that the
addition of the pharmacological amount of atRA was able to
substitute for ROL, at least until E10.5, and thus, late fetal
resorption that normally occurs when retinoid is limiting was
prevented. In the key group VI, we sought to institute a state of
late VAD by feeding the pharmacological amount of atRA
(250 μg atRA/g diet) from E8.5 to E10.5 (to prevent early
VAD-induced fetal resorption), followed by feeding of the low
level of atRA (12 μg/g diet) until E18.5. Provision of the
pharmacological amount of atRA during this short, but critical
window of time (E8.5–10.5) enabled the majority of fetuses
(72%) to survive to E18.5. This work showed that it was
possible to prevent late fetal resorption that normally
accompanies early vitamin A-deficiency during pregnancy by
adding a high level of supplemental atRA starting at the late
gastrula/early neurula stage in the developing rat embryo. The
ability to overcome VAD-induced fetal resorption enabled us to
produce a well-defined and reproducible state of vitamin A
deficiency during later stages of embryonic development; the
detailed morphology of these fetuses will be discussed below.
Two additional groups were given the pharmacological
amount of atRA (250 μg/g diet) for a more extended period,
from E8.5 to E18.5, either with (group VII) or without (group
VIII) supplemental ROL starting at E9.5. Both dietary regimens
supported fetal survival to E18.5 (93% and 92%, respectively,
similar to that of groups I, III, V and VI). These fetuses were
also examined in detail to determine if a high level of atRA
alone could support organ development to E18.5, and if not,
whether the outcome was improved if ROL was also provided
concurrently.
Severe abnormalities result from late vitamin A deficiency
The development of a variety of organs and tissues from
fetuses in groups I to VIII were scored as morphologically
normal (Tables 1 and 2; open box), severely abnormal (black
box) or having a developmental defect that was still apparent,
but showing some rescue in development (grey box) compared
to that defined as severely abnormal. These results show that
normal embryonic development is supported in full to E10.5
by atRA (low level E0.5 to E8.5 and high from E8.5 to
E10.5), after which time limiting the amount of atRA induces
a highly penetrant state of late fetal deficiency (group VI;
Tables 1 and 2).
Eye, nasal and salivary gland development
All fetuses (6/6) in the late VAD group (VI) developed
severe eye and nasal abnormalities by E18.5 (Figs. 2C, F and
Table 1) whereas development of these tissues was normal in
the VAS groups that received ROL starting either at the onset of
pregnancy (group I; Figs. 2A, D and Table 1) or after E9.5
(group III; data not shown). The vitamin A sufficient (VAS)
fetuses had closed eyelids, a well-formed retina containing two
layers, and two cell-free regions – the anterior chamber and the
vitreous body (Fig. 2A). Eye morphology in the group V fetuses
was similar in all respects to that of the VAS groups I and III. In
contrast, 100% of the late VAD fetuses (group VI; Fig. 2C) had
Table 1
Summary of the defects in the head and neck region of late VAD fetuses
Organs and tissues were scored as normal (open box), mildly abnormal (grey box), or severely abnormal (black box). The percentage of fetuses showing any
abnormality (mild or severe) is shown underneath the box.
aWarkany and Schraffenberger (1944); bWarkany and Schraffenberger (1946); cLohnes et al. (1994); dMolotkov et al. (2006); eDupe et al. (2003).
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the anterior chamber of the eye was missing and the lens was
fused with the cornea (Fig. 2C). In the late VAD fetuses, both
the size of the nasal turbinate cartilage and nasal cavity were
severely reduced, and the serous glands (Fig. 2F) and salivary
glands (data not shown) were missing in all fetuses. Importantly,
the addition of ROL after E10.5 (group V) rescued all of the eye
(Fig. 2B and Table 1), nasal, and glandular defects (Fig. 2E and
data not shown) observed in the late VAD group, confirming
that the defects observed in group VI were attributable to
retinoid deficiency imposed after this time.
Lung, diaphragm, and cardiac development
All of the fetuses in the late VAD group VI showed severe
abnormalities in the lung and diaphragm, and to a much lesser
extent, in cardiac development (Table 2). In the VAS groups
(I, III and V) the left lung was composed of one lobe and the
right lung had four lobes (cranial, caudal, middle, and acces-
sory; Figs. 2G, H, and data not shown). All of the late VAD
group VI fetuses showed bilateral hypoplasia of the left, cranial
and caudal lobes, with nearly a complete loss of the accessory
and middle lobes (Fig. 2I). In VAS fetuses, the development of
both the left and right domes of the diaphragm was complete
(Figs. 2J, K), whereas herniated diaphragm and protrusion of
the liver into the pleural cavity was observed in 100% of the late
VAD group VI fetuses (Fig. 2L; Table 2). The location of the
pericardial membrane suggested that pericardial edema was alsoa feature in all late VAD fetuses (Fig. 2I). Additional defects that
were observed only infrequently in the late VAD group included
incomplete development of the interventricular septum, a distal-
arising right subclavian aortic arch and an aorta receiving blood
from both ventricles in one fetus, and a second had a right-sided
aortic arch (data not shown). The low penetrance of these
defects suggests that 250 μg atRA/g diet supported aortic arch
and septal development and that these processes were
completed in the majority of fetuses by E10.5; the two affected
fetuses may still have been completing the development of these
retinoid-dependent structures when deficiency was imposed
after E10.5. This conclusion is supported by the finding that
none of these defects were observed in any of the fetuses in the
group receiving ROL following the high RAwindow from E8.5
to 10.5 (group V; Table 2).
Kidney, intestinal, and genital organ development
In all VAS fetuses (groups I, III and V) the kidney was
situated normally, posterior to the adrenal gland in the lumbar
region of the fetus, and the right and left kidney were separated
by the width of the vertebral column (Figs. 2M, N and data not
shown). The ureters were dilated (open) normally and ended in
the base of the urinary bladder (Figs. 2M and N). In contrast,
100% of late VAD group VI fetuses showed hypoplastic
kidneys that were fused at the sagittal midline (horseshoe
kidneys; Fig. 2O; Table 2). The renal pelvis and ureter were not
open in any of the specimens (Fig. 2O), and the ureter ended in
Table 2
Summary of the defects in the heart, lung, diaphragm, intestine, kidney, ureter and genital tract of late VAD fetuses
Abnormalities are displayed as in Table 1.
aWarkany and Roth (1948); bQuadro et al. (2005); cWilson and Warkany (1949); dMendelsohn et al. (1994); eWilson et al. (1953); fWilson and Warkany (1948).
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not shown). In addition, in all the late VAD group VI fetuses, the
fused kidneys were situated ectopically (more caudal) in the
lower lumbar/upper pelvic region. Most of the late VAD fetuses
also showed less extensive growth of the intestinal villi in the
small intestine (compare Fig. 2O to Fig. 2M and Fig. 2N).
Genital organ development in the rat is not normally complete
until E20.5. Prior to this time (E16–E18), the testes must
descend to the pelvic region where they assume their final
position in proximity to the urinary bladder. This process
occurred normally in the VAS fetuses, whereas the testes failed
to descend properly in all male late VAD fetuses (Table 2;
compare Fig. 2P and Fig. 2Q to Fig. 2R). Collectively, the work
summarized in Tables 1 and 2 and the sections shown in Fig. 2
show that group VI displayed defects with very high penetrance
and demonstrate that this dietary approach can be used to
produce a defined state of late fetal VAD.
Provision of high dietary atRA from E8.5 to E18.5 results in a
partial rescue of the defects observed in the late VAD fetuses
We next sought to determine whether administration of the
high atRA (250 μg/g diet) alone from E8.5 onward wouldsupport or improve organ development to E18.5. The develop-
ment of some organs in fetuses receiving the high atRA from
E8.5 to E18.5 was clearly improved compared to the late VAD
group VI (Tables 1 and 2). In particular, the severity of eye,
nasal cavity, lung and kidney defects was significantly reduced
in the group receiving prolonged high atRA (group VIII)
compared to the late VAD group VI, whereas the development
of the diaphragm, ureters and genital organs was improved only
slightly or not at all. It is notable that in the group (VIII)
receiving the 250 μg atRA/g diet from E10.5 to E18.5, the
development of the eye was considerably improved, and the
retina was no longer folded although it was somewhat thicker
than that seen in the VAS groups (compare Figs. 3B to Figs. 2A
and B; Table 1). Nasal cavity development was improved, and
the nasal cavity was less severely reduced in size in 83% of
fetuses in group VIII compared to VI (compare Fig. 3D and Fig.
2F). Only 50% of the fetuses from group VIII showed severe
lung hypoplasia compared to 100% of the late VAD fetuses
(group VI; Table 2; compare Fig. 3F to Fig. 2I). In the fetuses
exposed to the higher level of atRA to E18.5, the kidneys were
no longer fused and were found at the appropriate cranial to
caudal position, although they were still situated too close to
each other (Fig. 3H). In addition, half of the group VIII fetuses
176 A.W.-M. See et al. / Developmental Biology 316 (2008) 171–190showed the normal opening of the renal pelvis and the ureter
whereas these structures were never open in any of the late VAD
fetuses. Importantly, the addition of ROL to the pharmacologic
level of atRA (group VII) led to a complete rescue in develop-ment of all of these organs. These results show that the
pharmacological level of atRA alone improved development,
but was not sufficient to meet the total retinoid needs of several
organ systems during the latter part of gestation.
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fetal organ defects
A second study was performed to determine whether
reducing the amount of atRA from 12 to 1.5 μg atRA/g diet
after E10.5 would further perturb late fetal development (Fig.
4). In this study, fetuses were recovered at E21.5. All fetuses
from the VAS control group that received the high amount of
atRA from E8.5 to 10.5 followed by supplemental ROL after
E10.5 showed normal organ development (group IX, Fig. 4), as
did those receiving retinol starting at E0.5 (data not shown). The
late VAD group X supplemented with the lower level of atRA
(12 μg/g diet) after E10.5 showed developmental defects at
E21.5 similar to those observed in the late VAD group VI
fetuses examined at E18.5 (compare Figs. 4B, E and H to Figs.
2I, O and F, respectively), however additional defects were also
revealed (see below). When the atRA at E10.5 was reduced to
1.5 μg atRA/g diet (group XI), the development of a number of
organs including the lung, kidney (Figs. 4C, F), heart and
diaphragm (data not shown) was further compromised. Lung
hypoplasia was more severe in group XI fetuses (compare Fig.
4C to B). In the 1.5 μg atRA/g diet group (XI), the kidneys were
fused, and underwent even more severe hypoplasia than in the
12 μg atRA/g group (compare Fig. 4E and F). Moreover, in the
fetuses given the lowest amount of atRA, the kidneys were
situated even lower in the pelvic region. Thus, for some organs,
reduction of atRA from 12 to 1.5 μg/g diet increased the
severity of the VAD-related defects.
Several additional developmental defects were observed in
both the 12 and 1.5 μg/g diet groups at E21.5 that were not
evident at E18.5. All late VAD fetuses in groups X and XI
showed complete Harderian gland agenesis (data not shown). In
addition, there was no communication between the nasal and
oral cavities (choanal atresia) (Figs. 4H, I), and the maxillary
sinus was also missing in both groups of late VAD fetuses.
Imposition of late VAD reveals novel roles for vitamin A in the
developing skeleton
Development of the head (cranial region), axial skeleton,
pelvis and limbs was examined in group IX, X and XI fetuses at
E21.5 of development. As a control for these studies, the VAS
group IX fetuses were first compared to those given RP at either
E0.5 or E8.5 (Kaiser et al., 2003) and these three groups wereFig. 2. Abnormalities in late VAD group VI fetuses. Transverse sections of E18.5 fetu
(G–I), diaphragm (J–L), kidney and intestine (M–O) and male genitalia (P–R). Organ
In the VAD eye (C), note the everted/folded retina (er), open eyelid (bracket), loss of
corneal–lenticular stalk (cl). The cell free region posterior to the lens or vitreous b
reduction in size of the cartilage primordium of the nasal turbinate bone (tb) and nasal
lung hypoplasia and pericardial edema in the late VAD group VI specimen (I). The d
domes, right (rd) and left (ld) (J, K). In the late VAD specimen (L), the right diaphragm
kidneys in the abdominal region and the openings present in the renal pelvis (p) and u
(O) shows fusion of the left and right kidneys that are also hypoplastic and abnorm
intestinal villi (in and panels O and R). The testes (t) are positioned normally in the V
(R) is situated in the lumbar region instead of lateral to the urinary bladder (ub) in th
intestine; ir, neural layer of retina; j, conjunctiva; ll, left lung; lmb, left main bronc
epithelium; on, optic nerve; or, retinal pigmented epithelium; pm, pericardial memb
eyelid; filled arrowhead, closed eyelid.found to be normal (Table 3 and data not shown). A similar
pattern of defects was observed in both late VAD groups (X and
XI); although in some cases, the penetrance was slightly higher
in the group receiving the lowest atRA-containing diet.
Importantly, the penetrance of most defects approached 100%
when the number of fetuses showing any defect (bilateral or
unilateral) was considered.
Cranial structures of late VAD fetuses
While imposition of low atRA after the E10.5 stage did not
cause gross malformations of the cranial region, it did result in
obvious hypoplasia and minor malformation of many of the
cranial structures (Fig. 5B). Analysis of the overall length of the
dentary, nasal, and incisor bones revealed statistically signifi-
cant reductions in the late VAD groups compared to the VAS
control group (supplemental Table 1), whereas the VAS group
did not differ from a control group receiving retinol from the
onset of pregnancy (data not shown). The cartilage structures of
the nasal turbinates were markedly underdeveloped (Fig. 5D
and Table 3), and the supraoccipitals were notably smaller,
forming two “islands” as opposed to the normal butterfly shape
of this structure (Fig. 5B and data not shown). The medial
aspect of the basioccipital was malformed in 83% of the late
VAD fetuses in groups X and XI (Fig. 5D and Table 3). Minor
malformation or disorganization was seen in the cartilage of the
otic capsule; and the bones of the incus, malleus and stapes were
present but underdeveloped (data not shown). Notably, the
general patterning of the cranial region was preserved in both of
the late VAD groups X and XI.
Axial patterning
Late VAD fetuses from groups X and XI showed a sweep of
anterior homeotic transformation of vertebral identity from v1/
C1 through v10/T3, although not all landmarks were affected
(Table 3). This pattern was reversed in the regions of v17/T10,
v20/T13, and v27/S1, where evidence of novel posterior
homeotic transformations began to appear. The number of
presacral vertebra was maintained, with 26 presacral vertebra in
92–100% of the late VAD fetuses despite the many homeotic
shifts in identity.
Cervical region
The cervical region of late VAD fetuses from groups X and
XI was severely affected, with almost 100% penetrance (Tableses showing development of the eye (A–C), nasal region (D–F), lung and heart
development is normal in the vitamin A-sufficient (VAS) control groups I and V.
the anterior chamber (a), and fusion of the lens (l) with the cornea (c) forming a
ody (v) is replaced by fibrous tissue (retinolenticular fibroplasia, f). Note the
cavity (nc), and loss of the serous gland (sg) in the VAD fetus (F). Note the severe
iaphragm of fetuses in VAS specimens from groups I and V have two complete
atic dome is not complete. Note the normal position of the right (rk) and left (lk)
reter (u) in representative VAS specimens (M, N). The late VAD group VI fetus
al (pelvic) in location. This specimen also shows less extensive growth of the
AS fetuses in groups I and V (P, Q), whereas the testis in the late VAD specimen
e pelvic region. al, accessory lobe; ad, adrenal gland; cl, caudal lobe; i, iris; in,
hus; lv, left ventricle; le, liver; ml, middle lobe; ns, nasal septum; oe, olfactory
rane; pn, pancreas; rmb, right main bronchus; rv, right ventricle; s, stomach; y,
178 A.W.-M. See et al. / Developmental Biology 316 (2008) 171–1903). While the formation of the hyoid was the least affected, the
thyroid, cricoid and tracheal cartilages were severely malformed
in 83–100% of the late VAD fetuses, with splitting of the cricoid
body and partial to complete loss of the tracheal rings (Table 3
and Fig. 5F). The types of vertebral malformations were
consistent across and within litters and represented anterior
homeotic transformations of C1 through C7. The C1 vertebra in
late VAD fetuses showed dysymphysis of the neural arch, often
with a dorsal ossification spot that was either floating or fused to
the cranium (Fig. 6B, closed arrowhead, and not shown) in 92–
100% of late VAD fetuses. The ventral lamina of C1 attained an
exoccipital-like shape (Fig. 6B), and the anterior arch of the
atlas (aaa) was fused with the basioccipital (bocc) in the
majority of fetuses (Table 3). The neural arches of C2 throughC4 were most often fused, and all three vertebrae showed
evidence of anterior homeotic transformation, as the dorsal
aspect of the lamina took on the shape and characteristics of
vertebra further anterior (Table 3 and Fig. 6B, bracket).
Although C2 did not show full addition of an ectopic aaa, the
dens was fused with the bocc and/or the aaa in the majority of
late VAD fetuses, typically by a small cartilage bridge along the
dorsal aspect of the aaa (not shown). The neural arch of C3 was
split/duplicated (Fig. 6D, filled arrowhead), and the dorsal
lamina of vertebra C3 became C2-like in its curvature in 83–
100% of the late VAD fetuses in both groups (Fig. 6B). Further
posterior, there was evidence of transformation of C7 to C6, as
the ventral aspect of C7 gained an abnormally shaped tuberculi
anterior, and this structure was lost from C6 also suggesting a
C6 to C5 transformation (Fig. 6B).
Thoracic skeletal elements
Novel anterior and posterior transformations of the thoracic
region were observed in the late VAD fetuses. Specifically, v8/
T1 and v9/T2 were transformed to a more anterior identity, as
evidenced by a partial to complete loss of the v8 ribs and partial
loss of v9 ribs in 100% of fetuses examined (Fig. 6D and Table
3). This partial loss of ribs was also seen on v10 in up to 33% of
the late VAD fetuses in both groups. Interestingly, the dorsal
landmark of vertebral identity on v9, the processus spinosus,
was present in its normal location in late VAD fetuses (albeit
often smaller than normal; Fig. 6B) while the more ventral
identity of this vertebrae appeared to be anteriorized (i.e. partial
loss of rib). The sweep of anterior homeotic transformation
observed in v8 to v10 ended at some point beyond this axial
level, with clear evidence of a reversal or posteriorization events
beginning around v17/T10 (dorsal aspect) to v18/T11. In the
majority of VAS group IX control fetuses, the dorsal process of
the transitional vertebra v18 was flat, curving neither cranially
nor caudally (Fig. 6E). In group XI, the dorsal aspect of v18/T11
was curved cranially in 50% of the fetuses, indicating a possible
shift to a v19/T12-like identity; and the dorsal aspect of v17/Fig. 3. A pharmacological amount of dietary atRA from E8.5 to E18.5 rescues a
subset of the defects observed in fetuses made VAD after E10.5. High atRA
(250 μg/g diet) along with ROL starting at E9.5 (group VII, A, C, E and G)
resulted in development that was indistinguishable from group I receiving ROL
throughout pregnancy (Fig. 2). Eye, nasal, lung and kidney development in the
group receiving only the high level of atRA from E8.5 to E18.5 is markedly
improved compared to late VAD fetuses (compare Fig. 3B to Fig. 2C; Fig. 3D to
Fig. 2F; Fig. 3F to Fig. 2I; and Fig. 3H to Fig. 2O, respectively). In fetuses
receiving high RA to the end of pregnancy, the eyelid (y) is closed and the
anterior chamber (a) is present (Fig. 3B; Table 1). Note also that the retina in
group VIII is curved normally around the lens but appears thickened,
particularly in the region nearest the optic nerve (the posterior part of the
retina; bracket, B). The development of the nasal region is also improved,
however, the serous gland (sg) is still missing (D). The specimen receiving the
pharmacological level of atRA from E8.5 to E18.5 shows only mild lung
hypoplasia (F). Kidney development is improved as well in group VIII; the two
kidneys (rk, lk) are not fused at the sagittal midline as is seen in the late VAD
group VI (compare Fig. 3H and Fig. 2O) and the renal pelvis is dilated in half of
the group VIII fetuses. Development of the intestinal villi (in) is also improved
when the high level of atRA is provided to group VIII. Abbreviations are as in
Fig. 2.
Fig. 4. The effect of reducing material dietary atRA from 12 to 1.5 μg/g diet during the latter part of gestation (E10.5 to E21.5) on fetal organ development. Maternal
dietary treatment groups are shown in the top panel. Transverse (A to F) and frontal sections (G to I) are shown. Lung and kidney development is normal in a VAS
group IX fetus (A, D). A group X fetus showing hypoplastic lung development (B) similar that seen in the fetuses examined at E18.5 (Fig. 2I). Further reduction of
atRA in group XI produces even more severe hypoplasia in all four lobes of the lung (C). Fetus in group X showing fusion of the kidneys (E); group XI fetus with
severely hypoplastic fused kidneys located in the lower pelvic region, adjacent to the large intestine (li; F). Nasal region of a VAS fetus with the maxillary sinus (ms) is
shown in G, with the choana (ch) connecting the nasal cavity (n) to the nasopharynx (np). Choana is absent (choanal atresia) and agenesis of maxillary sinus is observed
in late VAD group X and XI fetuses (H, I). The survival of fetuses at E21.5 in groups X and XI (67% and 66%, respectively) is similar to that of group VI at E18.5. All
other abbreviations are as in Fig. 2.
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T11-type shift (Fig. 6F). In addition, 100% of the late VAD
fetuses receiving the lowest atRA diet (1.5 μg/g) and 33% in the
12 μg/g group showed a complete loss of the ribs at v20, at least
unilaterally, indicating a posterior shift of v20 to a v21-like
identity (Table 3 and Fig. 6F). Rib fusions were also observed in
the late VAD fetuses, with a high prevalence involving the ribs
in the region of v16 through 19, where the majority of fetuses in
both groups X and XI (91–100%) showed fusions (Fig. 6D,
bracket).
The sternum was grossly malformed in 100% of the late
VAD fetuses in both groups (Table 3, Fig. 6H). Only two to fourof the thoracic ribs were fused to the sternum and no distinct
sternebrae were formed; instead, there appeared to be a fusion of
the structures of the manubrium, sternebrae and xyphoid (Fig.
6H, asterisk). Fifty percent of the fetuses in both groups X and
XI had a split sternum, with fusion only at the anterior and/or
posterior aspect (Fig. 6H and Table 3).
Sacral and pelvic region
Novel malformations were also seen in the sacral and pelvic
elements of the late VAD fetuses. There was evidence
suggesting a posterior homeotic shift had occurred in the dorsal
and ventral cartilage processes of v27/S1 and v28/S2. The
Table 3
Presacral skeletal abnormalities in late VAD fetuses (% of total)
Shaded areas indicate normal characteristics. ‘----’: indicates 0% incidence. Percent indicates number of embryos affected bilaterally. Numbers in parentheses denote
embryos with only unilateral changes.
C, cervical; T, thoracic; v, vertebra.
an=11 analyzed.
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and became v28-like in shape (Figs. 7B, C, and Table 4). The
second sacral vertebra, v28, also had an altered dorsal process
that was fused with v27 and/or v29, as well as abnormal ventral
processes (Fig. 7E; open arrowhead). All fetuses from both late
VAD groups had only 2 or 3 vertebra attached at the pelvis
(Table 4 and Fig. 7E). The anterior aspect of the ilial bone was
both shortened and malformed, with a widening at the proximal
end and no evidence of the sciatic notch (Fig. 7G, compare to
Fig. 7F). Moreover, the attachment of the ilium to the spinal
column, normally a cartilagenous attachment limited to the
medial or inner aspect of the ilium, was markedly deformed. In
the late VAD groups, the iliac bone developed a bridge of
cartilage curving over the dorsal aspect of the bone andattaching to v27 and v28 (Figs. 7B and C, dashed lines). Fig. 7I
demonstrates the very narrowed and abnormal cartilage
attachment to the ilium in a late VAD fetus as compared to
the control (Fig. 7H), from the dorsal view. This cartilage defect
produced an abnormal articulation of the iliosacral joint, with
the pelvis and upper hindlimb being rotated ventrally away from
its normal alignment with the spinal column in the late VAD
groups X and XI (Figs. 7B and C, compare to the VAS control in
Fig. 7A).
Limbs
In both late VAD groups (X and XI), the development of
both the forelimb and hindlimb was abnormal when compared
to VAS control fetuses (group IX). The scapula of the forelimb
Fig. 5. Comparison of cranial and neck structures in VAS and VAD E21.5 fetuses. Dietary treatment groups are as shown in Fig. 4, top panel. (A) Side view of cranium
showing normal development in a control VAS fetus. (B) Group X fetus showing marked hypoplasia of the cranial elements. (C, D) Dorsal view of the ventral cranium,
with the dorsal portion of the skull removed. Note the loss of cartilage in the nasal turbinates (nt) and the malformed basioccipital (b) bone in the late VAD fetus shown
in panel D. (E) Ventral view of the hyoid (h), thyroid (t), cricoid (c), and tracheal cartilages (tr) showing normal development in a VAS fetus. (F) Late VAD fetus
showing gross deformation of the thyroid and cricoid cartilage, and absence of tracheal cartilage rings (closed arrowhead). al, alisphenoid bone; bs, basisphenoid; C1,
first cervical vertebra; d, dentary bone; e, exoccipital; f, frontal bone; ip, interparietal bone; nc, nasal capsule; n nasal bone; oc, otic capsule; p, parietal bone; px,
incisive bone; s, supraoccipital.
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caudal aspect (Fig. 7J, cranial= top). In both late VAD groups,
the proximal end of the cranial edge of the scapula was straight,
with the curve beginning about halfway down the length of the
bone in 100% of the fetuses examined (Fig. 7K, open
arrowhead, and Table 4). Further distal, the normal scapular
spine rises higher laterally as it continues distally to form the
long flat acromion process (Figs. 7J and L) that articulates with
the clavicle and shoulder joint. In almost all late VAD fetuses,
the scapular spine appeared hyper-extended laterally, resulting
in misdirection of the acromion process and a failure of
articulation with the clavicle and shoulder joint (Fig. 7M,
double arrowhead and Table 4). The coracoid process, which
emanates from the cranial aspect of the articular end of the
scapula, normally curves medially in a hooklike shape to
articulate with the shoulder joint. In the late VAD fetuses, the
coracoid process was somewhat hypoplastic and abnormally
rounded (data not shown). The ossification centers of the
proximal phalangeal and metacarpal bones were either missing
or greatly reduced in size in the distal forelimbs of all group X
and XI late VAD fetuses (Fig. 7K and data not shown).
The hindlimb of fetuses from both late VAD groups was
abnormal, showing hypoplasia of the proximal fibula, such that
normal articulation with the tibia and stifle joint did not occur
(compare Fig. 7O to Fig. 7N, and Table 4). Furthermore, as with
the thoracic limb, the ossification centers of the proximal
phalangeal and metatarsal bones were either missing or severely
reduced in size (data not shown).
Thus, both anteriorizations in the cervical and rostral
thoracic regions as well as novel posteriorizations in the caudal
thoracic and lumbosacral regions of the axial skeleton wererevealed in high penetrance in the late VAD fetuses. Overall,
there appears to be a need for vitamin A both for early axial
patterning as well as for the later development and maintenance
of identity for many skeletal elements.
mRNA analysis in late VAD embryos
In order to begin to explore the molecular basis for a number
of the skeletal defects appearing in late VAD embryos, studies
of Hoxd3, Hoxd4, Hoxb4 and Wnt3a mRNAs were initiated.
While no obvious differences in expression could be detected
between VAS and late VAD fetuses for either Hoxd4 or Wnt3a
at E11.5 or E12.5, Hoxd3 mRNA expression was clearly
changed in VAD embryos at E11.5. There was a decrease in
Hoxd3 message in VAD group X and XI embryos in the region
of pharyngeal arches 3,4 and 6, whereas expression in other
areas appeared unchanged from VAS controls (Figs. 8A and B).
This is significant, as the third pharyngeal arch contributes to
the body of the hyoid bone (lower rim and greater horn) whereas
the cartilage of the larynx originates from the fourth and sixth
arch mesoderm, and Hoxd3 plays a role in the formation of
these structures (Condie and Capecchi, 1994; Manley and
Capecchi, 1997). In contrast, by E12.5, late VAD fetuses
showed a clear increase in Hoxd3 expression and a persistence
of signal in the region of somites 22/23, a site where expression
was becoming less distinct in the VAS embryos (Fig. 8D and
inset). This is interesting, as somites 22/23 contribute to the
patterning of vertebra 17 through 19, the region where
posteriorization of axial identity begins to become evident in
late VAD fetuses. Hoxb4, which is needed for proper closure of
the ventral body wall as well as normal sternal development
(Ramírez-Solis et al., 1993; Barrow and Capecchi, 1996), was
Fig. 6. Homeotic transformations and malformations in the cervical and thoracic regions of late VAD fetuses at E21.5. Numbers indicate vertebra number; in panels C
and D, the most anterior ribs are also noted. (A) Side view of cervical region showing normal skeletal elements in a VAS fetus. (B) Late VAD fetus showing fusion of
the cervical arches of v1–v3 (bracket) and anteriorization of v7 (tuberculi anterior, ta, on C7) and v8 (loss of rib, open arrowhead). The closed arrowhead in panel B
indicates a floating ossification body above C1. (C) Side view of the thoracic region showing normal development in a group IX fetus. (D) Late VAD fetus showing
anteriorization and posteriorization events in the thoracic region. Note rib fusions on v16–v18 (bracket), loss of rib on v8 (open arrowhead, anteriorization) and partial
loss of the rib on v20 (posteriorization), and sternal malformation (asterisk). (E) Close view of vertebra in the transitional region of the thoracic spinal column (v17
through 20), showing the normal flattened dorsal process on v18 and rib on v20. (F) Late VAD fetus with posteriorization of the dorsal process of v17/v18 and loss of
the rib on v20 (curved arrow). (G) Ventral view of the sternum showing normal development of the manubrium (m), sternebrae (sb), xyphoid process (x) and ribs in a
VAS fetus. (H) Late VAD fetus showing gross malformation of the sternal elements as well as loss of ribs attached to the sternum. The asterisks in panels D and H
indicate fusion of the manubrium, sternebrae and xyphoid process in late VAD fetuses. aaa, anterior arch of the atlas; e, exoccipital; ps, processus spinosus.
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medial to the cartilage primordium of the sternum (Fig. 8F),
whereas it was expressed at a similar level to that of the VAS
controls in the spinal cord (Figs. 8E and F; insets). These
preliminary findings suggest that changes in expression of at
least two Hox gene family members (Hoxd3 and Hoxb4) could
play a role in the skeletal changes that result from imposing
VAD after E10.5 in the rat, although there are likely to be many
other gene changes that contribute due to the pleiotropic nature
of atRA action. The reduction in Hoxd3 expression that is
observed in late VAD embryos at E11.5 also suggests that a state
of VAD is imposed in embryos very rapidly (within 24 hours)
after reducing the maternal dietary intake of atRA, and is inagreement with the short half-life of the vitamin A acid reported
in vivo (Roberts and DeLuca, 1967).
Discussion
Nutritional approaches have been used successfully to
evaluate the need for vitamin A early in mammalian embryo-
genesis, whereas the ability to induce VAD at later times has
been hampered by the high lethality that occurs when retinoid is
limiting. In this paper, a nutritional model is described that
produces vitamin A deficiency in rat fetuses during later
gestation (late VAD). This is achieved by supplying atRA in the
diet to pregnant VAD female rats, first at a low level, and then at
Fig. 7. Malformations in the pelvic and sacral regions, and in limbs of VAS and VAD fetuses at E21.5. Numbers indicate vertebra number. (A) Side view of sacral
region of a VAS fetus depicting normal development and attachment of the ilium (i; solid outline) and characteristic shape of the dorsal processes of v26–v29. (B) Late
VAD (group X) fetus showing moderately abnormal attachment of the ilium and widened anterior ilium (dotted outline indicates abnormal bridge of dorsal cartilage to
v27/v28) as well as posteriorization of the dorsal processes of v26 and v27. (C) Group XI fetus showing severely abnormal ilium and attachment at sacrum (dotted line
indicates abnormal dorsal cartilage attachment) and posteriorization events in v26–v28. (D) Ventral view of the sacrum of a VAS group IX fetus showing normal pelvic
and sacral development. (E) Ventral view of late VAD fetus with marked deformation of the sacral attachment and abnormal lateral processes of v28 and v29 (arrow).
(F) Medial (inner) view of the ilium of a control fetus showing normal shape of the ilium and sciatic notch (sn). (G) Ilium of a group X fetus with shortened, widened
anterior aspect of ilium and loss of the sciatic notch. (H) Dorsal view of ilium (medial to left, lateral to right) of a VAS control fetus. Brackets indicate the area where the
normal cartilage attachment to the sacral vertebra is located on the medial (inside) aspect of the bone. (I) Dorsal view of ilium of a group X late VAD fetus showing the
abnormal dorsal cartilage that bridges to the sacral vertebra. Late VAD fetus showing hypoplastic forelimb (K, M) and hindlimb (O) when compared with VAS fetus (J,
L, N). Note the abnormal shape of the cranial border of the scapula in the late VAD fetus (K; open arrowhead) whereas it is concave in shape in the VAS fetus (J). In the
VAS fetus, the spine of the scapula (ss) articulates to the humerus (h) and to the clavicle (c) through the acromion process at the acromioclavicular joint as shown in
panel L, which shows side view of the scapula blade (sb). In the late VAD fetus, the spine of scapula and the acromion are hyperextended and project further away from
the scapular blade than normal (M; double arrow). Close-ups of hindlimbs are shown in panels N and O. The fibula (f) articulates to the femur (fe) in the VAS fetus (N),
whereas in late VAD fetus, the fibula is hypoplastic and does not form the tibiofibular articulation (asterisk, F). ca, calcaneum; cp, coracoid process; dt, deltoid
tuberosity; i, ilium; is, ischium; mf, medial fabella; od, ossification center in distal phalangeal bones; om, ossification center in metacarpal bone; op, ossification center
in proximal phalangeal bone; pa, patella; p, pubis; r, radius; sc, scapula; t, tibia; u, ulna.
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corresponds to the late gastrula/early neurula stage to around
the 12–15 somite stage. When a diet containing a lower level ofatRA is reinstituted after E10.5, a well-defined state of vitamin
A deficiency is produced revealing defects in organogenesis and
skeletal development (Tables 1 and 2). A subset of the defects
Table 4
Sacral and limb abnormalities in late VAD fetuses (% of total)
Shaded areas indicate normal characteristics. Percent indicates number of embryos affected bilaterally. Numbers in parentheses denote embryos with only unilateral
changes.
v, vertebra.
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in the 1940s and 50s coined the “vitamin A deficiency
syndrome” (Warkany and Schraffenberger, 1944, 1946; Jackson
and Kinsey, 1946; Warkany and Roth, 1948; Warkany et al.,
1948; Wilson and Warkany, 1949; Wilson et al., 1953).
However, in these early studies, the time to depletion and the
severity of the deficiency varied, the maternal and fetal survival
rates were low, and the non-eye-related defects were observedFig. 8. Hoxd3 and Hoxb4 mRNA expression in late VAD compared to VAS embryos.
Note the decrease inHoxd3 expression in the region of pharyngeal arches 3, 4 and 6 (b
The inset shows the slight increase in punctate dorsal staining in the region of somites
sections showing Hoxb4 expression in a VAS control embryo at E16.5 (E) and the re
spinal cord (insert) for comparison. cp, cartilage primordium; fl, forelimb; h, heart;only at low frequency (4–42%). Using the late VAD model
described here, not only do fetuses recapitulate most of the
defects described in these early studies, but the maternal and
fetal survival rates are much higher, and malformations are
observed in nearly 100% of the fetuses. The key methodological
improvement involves the use of the short half-life vitamin A
metabolite, atRA, thus enabling provision of an exact amount of
the retinoid at appropriate times in a form that cannot be stored.(A) Normal expression of Hoxd3 mRNA is seen in a VAS embryo at E11.5 (B).
racket).Hoxd3 staining in a VAS control (C) and late VAD (D) embryo at E12.5.
22 (asterisk) and 23 in the late VAD embryo compared to the control. Vibratome
duction in staining in the late VAD embryo. Equivalent staining is shown in the
s, somite; sc, spinal cord.
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high embryonic lethality in earlier studies are avoided in the
present model. Using this model, a defined state of fetal VAD is
attained, and the severity of defects in some tissues (lung,
kidney, heart and diaphragm) can be further modulated by
titrating the level of atRA included in the diet. This model can
now be extended to study the effects of VAD at specific times
during later development by varying the time when retinoid is
added back to the diet.
VAD syndrome-like defects have been reported in com-
pound, but not single, RAR null mutants, and it is noteworthy
that the penetrance of many of these defects is often quite low
(Lohnes et al., 1994; Mendelsohn et al., 1994; Grondona et al.,
1996). RARα−/−RARγ−/− fetuses showed the highest pene-
trance, however, there was a high embryonic mortality rate
(Lohnes et al., 1994). Raldh null mutants have also been used to
study the function of RA in developing embryos, but this
approach is complicated by the presence of multiple RALDH
enzymes (Duester et al., 2003; Dupe et al., 2003; Fan et al.,
2003; Matt et al., 2005; Molotkov et al., 2006) as well as a
newly described Cyp1B1 (Chambers et al., 2007), all of which
may contribute to the atRA that is present at varying times
during the development of the embryo. atRA supplementation
of mothers of Raldh2 null mutants has been shown to extend
survival to later times (E18.5), but only a very small number of
mutants were rescued (2 fetuses out of 12 litters) (Wang et al.,
2006). Thus, the late VAD rat model described here represents a
means whereby the developmental effects of deficiency can be
studied in a model with high fetal survival and penetrance of
defects.
In addition to recapitulating many of the defects described by
Warkany and colleagues, the late VAD model has revealed
malformations not observed in these early studies. In some
cases, these late VAD defects show similarity to those observed
when a genetic approach is used to alter retinoid signaling.
Specifically, the choanal atresia observed in Raldh3−/− fetuses,
absence of salivary glands in RAR compound mutants (Lohnes
et al., 1994), and agenesis of the Harderian glands found in
RAR compound mutants, Raldh3−/− (Dupe et al., 2003) and
Raldh1−/−Raldh3−/− mutants (Matt et al., 2005) are also seen in
late VAD rat fetuses. Nasal cavity development begins in the
mouse at E9.5 (11–11.5 in the rat), and the timing of late VAD
coincides with a time when an effect on this structure would be
expected. The present work proves that a lack of vitamin A is
clearly the precipitating event leading to these defects, as
opposed to the involvement of RALDH or RAR in other
metabolic or signaling pathways. Thus, these embryonic defects
can now also be considered part of the VAD syndrome.
In the present model, because VAD is imposed after E10.5
(∼12–15 somite stage), the late VAD fetuses differ somewhat
with respect to lung and heart changes when compared to those
reported as part of the early VAD syndrome and in genetic
models that alter retinoid signaling during all stages of em-
bryonic development. In late VAD rat fetuses, the lungs are
hypoplastic, but no agenesis is observed. In contrast, left lung
agenesis and lung hypoplasia was reported by Warkany and
colleagues (1948) and Wilson et al. (1953), and was alsoobserved in RAR compound mutants (Mendelsohn et al., 1994),
RBP (Quadro et al., 2005) and Raldh2 mutants supplemented
with RA (Wang et al., 2006). Lung development starts at
approximately E10.5 in rat embryos (E9 in mouse; Maeda et al.,
2007) and the lung buds arise from the foregut endoderm
followed by branching of the bronchial tree starting at
approximately E13 in rats (E11.5 in mouse; Kaufman, 1992).
Lung agenesis may have resulted from disruption in retinoid
signaling during lung bud formation, whereas, in the late VAD
model, the pharmacological level of atRA (250 μg atRA/g diet)
provided from E8.5 to E10.5 supported budding of lung from
the foregut. However, the low atRA diet (12 μg atRA/g diet)
after E10.5 was clearly insufficient to support the branching and
growth of the lung that happens during later gestation yielding
hypoplasia.
Cardiac and aortic arch defects were infrequently observed in
late VAD fetuses in the present study when compared to other
models (Wilson and Warkany, 1949; Mendelsohn et al., 1994).
The heart is the first organ to develop in the embryo, starting at
approximately E7–7.5 in the mouse (E9–9.5 in rat) when the
intra-embryonic mesoderm splits to form the intra-embryonic
coelom (Kaufman, 1992). The pericardial coelom continues to
develop and by E8–8.5 in the mouse (E10–10.5 in rat), the
cardiac primordium is undergoing looping and the primitive
vasculature is established. The pharmacological amount of
atRA consumed by dams during midgestation prevented the
majority of the cardiac and aortic arch defects from occurring in
the majority of late VAD fetuses. Thus, the model presented
here can be used to address the importance of timing of retinoid
sufficiency in relationship to the development of specific
embryonic structures without significant lethality due to
disruption of heart development.
Although much of skeletal patterning is initiated early in
development, the process of chondrocyte migration, differentia-
tion and subsequent ossification occurs later. Skeletal staining
of late VAD fetuses reveals novel malformations of both axial
and appendicular skeletal elements, including homeotic trans-
formations that include both anteriorizations and posterioriza-
tions at different axial levels in the same fetus. Using a
nutritional approach to impose VAD at earlier times during rat
embryonic development (bE10.5), our group showed pre-
viously that vitamin A plays a critical early role in patterning the
entire axial skeleton (Kaiser et al., 2003). The present study now
clearly demonstrates that vitamin A also plays key roles at later
times in the maintenance of vertebral identity and in the
development other structures. Interestingly, skeletal abnormal-
ities were not originally reported as part of the VAD syndrome,
but they were reported in the cranial and cervical regions of
RAR single (Lohnes et al., 1993) and compound (Lohnes et
al., 1994) null mutant mice. Thus, our work shows that skeletal
abnormalities should be added to the VAD syndrome, and
confirm the necessity for ligand in these processes. Because the
late VAD model also produces novel malformations, it either
must represent the most severe dampening of vitamin A
signaling produced to date, and/or shows that a loss of ligand-
dependent repressive function impacts development more
severely than does the absence of receptors. The importance
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the thyroid hormone field, where the effect of thyroid hormone
deficiency is more severe than the loss of thyroid hormone
receptors (Eckey et al., 2003).
Comparison of the effects of early and late VAD to the defects
observed in genetic models that perturb vitamin A signaling also
now enables us to define when during development vitamin
A-dependent processes are altered. Several regions of the late
VAD skeleton are less severely affected than in genetic models
that interfere with vitamin A signaling for the entire course of
embryogenesis. In the craniofacial region, the loss of midfacial
structures seen in RARα−/−RARγ−/− compound (Lohnes et al.,
1994) or RBP (Quadro et al., 2005) knockout models is not ob-
served the late VAD fetuses presented here. Likewise, in late VAD
fetuses, the most distal regions of the forelimb and hindlimb are
somewhat hypoplastic, but overall, these appendages are pat-
terned appropriately. This contrasts with the RARα−/−RARγ−/−
mutants, where ectrodactayly and polydactyly are observed
(Lohnes et al., 1994). This shows that provision of an amount
of atRA that supports normal growth and cellular differentiation
in the adult (12 μg atRA/g diet) to E8.5 followed by higher
RA to 10.5 is sufficient to support early patterning and devel-
opment of facial structures and distal regions of the limb in the
embryo.
There are similarities between fetal defects induced by the
late VAD model and compound RAR null mutant mice, par-
ticularly in the upper cervical regions of the skeleton. Late VAD
causes a high penetrance of defects of the thyroid, cricoid and
tracheal cartilages, similar that reported in RARα−/−RARγ−/−
mutants (Mendelsohn et al., 1994) whereas these defects are notFig. 9. Schematic summarizing how vitamin A deficiency imposed at different tim
vitamin A deficiency (deficiencyNE10.5; groups X and XI) leads to both anterior and
developmental times (between E9.25 and 9.75) show only anteriorizations extending
Fetuses showing normal development (VAS) include those given retinol at E0.5, or th
atRA/g diet (E8.5–E10.5) followed by retinol at E10.5 (group IX) or supplemented
basioccipital; d, dens; dp, dorsal process; ex, exoccipital; na, neural arch; ps, processus
S, sacral. ⁎indicates transformation to a different vertebral identity.seen in early VAD. Interestingly, imposition of VAD after E10.5
resulted in down-regulation of Hoxd3 at E11.5 in the caudal
pharyngeal arches (3, 4 and 6). These regions contribute to the
hyoid and laryngeal cartilages, and deletion of Hoxd3 has been
shown to enhance the Hoxa3 mutant phenotype in the laryngeal
cartilages (Condie and Capecchi, 1994), and Hoxd3/Hoxb3
double mutants show defects in the throat cartilages and
bones that are not seen by mutation of either individual gene
(Manley and Capecchi, 1997). Deformation of C1 was reported
in RARα−/−RARγ−/− mutants and is also seen when VAD is
imposed either early or late; however the VAD phenotypes vary
depending upon the timing of the deficiency. Early VAD
(E9.25–E9.75) causes a posterior shift in the expression of
Hoxd3 and Hoxd4 in the somitic mesoderm and anteriorization
of C1 and C2 (Kaiser et al., 2003), whereas this shift inHox gene
expression was not observed in late VAD embryos (Fig. 8 and
data not shown). Interestingly, marked agenesis of the neural
arch of C1 is not seen with high penetrance in early rescued VAD
fetuses, but is found with very high penetrance (92–100%) in
late VAD fetuses in the present report. It is only in late VAD
fetuses that formation of an ectopic bone element in the dorsal
cervical region of C1 is observed. The malformations due to late
VAD in this region are strikingly similar to those reported by
Lohnes and colleagues (1994) in RARα−/−RARγ−/− mutants, in
which both agenesis of the C1 neural arch and ectopic bone
elements in the cervical region were noted. The fact that tracheal
defects do not occur and ectopic bone in the region is not found
unless deficiency is imposed after E10.5 would indicate that it is
not only signaling through the RARs, but signaling beyond the
12 to 15 somite stage that is crucial.es during development alters vertebral development and axial patterning. Late
posterior vertebral transformations, whereas fetuses deficient in retinoid at earlier
from v1 to v30 (adapted from Kaiser et al., 2003 and unpublished observations).
ose fed a diet containing 12 μg atRA/g diet and either supplemented with 250 μg
with retinol before E9.25 (Kaiser et al., 2003). a, anterior arch of the atlas; b,
spinosus; ta, tuberculum anterior; v, vertebra. C, cervical; T, thoracic; L, lumbar;
Table 5
Comparison of skeletal defects in late VAD fetuses with early VAD and genetic








Loss of midfacial structures No Yes c, d No e
Hypoplastic cranial bones Yes Yesc,d No
Thyroid and cricoid cartilages
abnormal
Yes Yes f Noe
Tracheal rings lost Yes Yesf Noe
Axial skeleton
Homeotic transformations
Basioccipital with aaa fusion Yes Yesc, g Yes
Anteriorization of C1/C2 lamina Yes Yesc,g Yes
Anteriorization of C7 to C6
(ta on C7)
Yes Yesc,g Yes






Posteriorization of v17/v18 to
v18/v19
Yes NR No







Loss of C1 neural arch Yes Yesc,d Yes
Ectopic bone in dorsal
cervical region
Yes Yesc No
Loss of C2 neural arch Yes Yesc No
Rib fusions v8 and v9 Yes Yesg Yes
Rib fusions v13–15/v16–19 Yes NR No
Sternal splitting and loss
of sternebrae
Yes Yesc,d Noe
Iliosacral joint malformation Yes NR No
NR, not reported.
a Time when embryos were retinoid-deficient.
b Kaiser et al. (2003).
c Lohnes et al. (1994).
d Quadro et al. (2005).
e Kaiser and Clagett-Dame, unpublished observations.
f Mendelsohn et al. (1994).
g Lohnes et al. (1993).
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show both anterior and posterior homeotic axial skeletal trans-
formations. This is in striking contrast to the effect of early VAD
that results in a sweep of anteriorization extending from v1 to
v30 (Fig. 9). The importance of atRA as a posteriorizing factor
in the cervical region of the axial skeleton has been de-
monstrated both in fetuses made VAD prior to E10.5 (Kaiser et
al., 2003) and in genetic models in which RARs are disrupted
(Lohnes et al., 1993; 1994). Interestingly, both in the cervical
region (C2–C7) and at the cervical/thoracic junction of late
VAD fetuses, homeotic shifts representing anteriorizations are
observed. The anteriorizations produced by late VAD are,
however, completely prevented when high atRA is given from
E8.5 to E10.5 followed by retinol, showing that it is VAD after
E10.5 that is responsible for the malformations seen in the
present study. The presence of RARα and γ transcripts in
sclerotomes of the mouse (Ruberte et al., 1990, 1991; Dolle et
al., 1990) supports the idea that atRA may act directly in this
tissue to support later maintenance of vertebral identity. At the
thoracic junction, the late VAD model continues to yield
anteriorization events, as evidenced by the loss of ribs at v8 and
the presence of partial ribs at v9, with 100% penetrance.
However, the dorsal landmark of identity on v9, the processus
spinosus, is in place, indicating a differential effect of late VAD
on the dorsal and ventral identity of v9. These late VAD-
induced changes contrast with those of RARα−/−RARγ−/−
compound knockouts in which posterior transformations
occur at this junction, with the addition of ribs on C6 and C7
(Lohnes et al., 1994). The VAD fetuses do, however, reveal two
very striking novel posteriorization events in more caudal
regions of the skeleton. Vertebra 17 through 20 (T10–T13)
appear posteriorized, as evidenced by the change in the
transitional vertebra shown and the loss of a rib on v20
shown in Fig. 6F. Although these defects have not been reported
in any genetic models that disrupt vitamin A signaling, similar
defects have been reported by Ikeya and Takada (2001) in Wnt-
3avt/vt mutant mice, in which posteriorization of the transitional
vertebra (dorsal aspect) and loss of the ribs on v20 is reported.
We could not detect any changes in Wnt3a expression in late
VAD embryos at either E11.5 or E12.5. However, we did
observe higher levels of Hoxd3 expression at E12.5 in late VAD
embryos in this key region (somites 22/23). These somites
contribute to v17–v19, and correspond to the region where we
see posteriorization of the dorsal neural arches and a loss of the
rib on v20. It is possible that aberrant persistence of Hoxd3
expression in this region could contribute to the mispatterning
(posteriorization) in the late VAD groups, or at least indicates
that there is aberrant gene expression that results from late VAD
in this region. Further caudal in VAD fetuses, the dorsal pro-
cesses of sacral v27 and v28 both show evidence of poster-
iorization. These more posterior homeotic transformations are
in clear contrast with the RARα−/−RARγ−/− mutant, in which no
homeotic changes beyond the cervical/thoracic junction are
reported. Because late VAD embryos are devoid of all vitamin
A except that provided in the form of atRA to the maternal
organism, the patterning effects in our model may represent a
more complete impairment of vitamin A signaling compared tothe situation when only two RAR subtypes are missing yet the
retinoid biosynthetic machinery remains intact.
In addition to changes in axial patterning, dramatic mal-
formation of the sternum and ribs occur due to late but not early
VAD (on or before E9.75; Kaiser and Clagett-Dame, unpub-
lished observations). Sternal development begins around E12 in
the mouse (Chen, 1952), therefore it is not surprising that the
development of this structure is strongly affected only when
VAD is imposed at later times (Table 5). The sternal
deformations seen here are more severe than those observed in
genetic models that perturb vitamin A signaling (Lohnes et al.,
1994; Quadro et al., 2005). Not only are the sternal bands not
fused in late VAD fetuses, but there is a complete absence of the
non-ossified regions that normally separate the sternebrae. Split
sterum and sternal malformations have been reported in Hoxb2
and Hoxb4 single as well as Alx4/Cart1 double homozygous
188 A.W.-M. See et al. / Developmental Biology 316 (2008) 171–190mice (Ramírez-Solis et al., 1993; Barrow and Capecchi, 1996;
Qu et al., 1999). The loss of Hoxb4 expression noted in the
ventral body wall adjacent to the cartilage primordium in late
VAD embryos may have contributed to the sternal malformations
observed in this group. The Hox genes are believed to play an
indirect role in closure of the sternal rudiments, and are known to
be regulated by atRA (Ramírez-Solis et al., 1993; Roelen et al.,
2002). In addition, ventral rib fusions from v16 to v19 are seen
with high frequency in late VAD, and may be similar to those
observed in RARα−/−RARγ−/− nulls (Table 5).
Novel and highly penetrant malformations of the pectoral and
pelvic regions are apparent in late VAD rat fetuses. In the
pectoral region, the acromion process is misdirected, and the
proximal region of the scapula is malformed. In the pelvic
region, there is an abnormal cartilage connection extending from
the ilium causing an aberrant rotation of the hindlimb away from
the spinal column. The scapula and ilium are the dorsal
components of the shoulder and pelvic girdles. Although the
pathways responsible for the formation of these structures are
not well understood, Emx2 is known to be essential for the
formation of structures of both girdles (Pellegrini et al., 2001),
Tbx15 and Alx4 play a role in anterior scapula development
(Kuijper et al., 2005), and Pax1 is needed for acromion
formation (Grüneberg, 1950; Timmons et al., 1994). None of
these are known atRA target genes, although Pellegrini and
colleagues (2001) have suggested that Emx2 expression could
be indirectly affected by atRA via the induction of Hoxc6.
Expression of Sox9 is essential for initiating chondrocyte
condensation and for chondroblast differentiation, and it
regulates the expression of Col2a1 that is expressed in cells
committed to enter chondrogenesis. Vitamin A is implicated as a
player in the process of chondrocyte differentiation (Weston et
al., 2003), and atRA has been shown to regulate Sox9 expression
in primary cultures of isolated mouse rib primary cartilage
(Sekiya et al., 2001) and limb mesenchyme (Weston et al.,
2002). Thus, VAD could affect formation of the scapula and the
acromion process by altering chondrocyte condensation and/or
differentiation. The first vestige of the acromion, as detected by
the expression of Col2a1mRNA, is found at E11.5 in the mouse
(Timmons et al., 1994) or approximately E13–13.5 in rat.
Therefore, the time when VAD is induced in rat fetuses overlaps
the time when the acromion would be forming. The defects in
the pectoral and pelvic regions in late VAD rat fetuses are
unique, as they are not observed in either the early VAD rat
model or in other genetic models that disrupt RAR signaling
(Table 5). The novel effects on skeletal development observed
in the late VAD fetuses further support the idea that this model
provides the most stringent negative effect on vitamin A
signaling when compared to the genetic models studied to
date.
In summary, we have developed a new model that can be
used to study the effects of embryonic vitamin A deficiency in
the rat after E10.5 of development. The fetal vitamin A
deficiency syndrome produced in this model is of similar
severity across affected fetuses, and many defects are
completely penetrant. Using this approach, we have assigned
new functions for vitamin A in the developing skeleton inrelation to the timing of deficiency, and we have revealed
unique defects that can be attributed to late VAD. The
nutritional model described herein enables deficiency to be
induced at a defined developmental time, and can be used to
study the role of vitamin A in the detailed development of organ
systems in the future.
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